about
G-CSF Predicts Cardiovascular Events in Patients with Stable Coronary Artery DiseaseSmall high-density lipoprotein is associated with monocyte subsets in stable coronary artery diseaseSoluble ST2 and interleukin-33 levels in coronary artery disease: relation to disease activity and adverse outcomeAssociation of small dense LDL serum levels and circulating monocyte subsets in stable coronary artery disease.Copeptin Predicts Mortality in Critically Ill Patients.Inflammation and coagulation in atherosclerosis.Anti-thrombotic and pro-fibrinolytic effects of levosimendan in human endothelial cells in vitro.Differential in vivo activation of monocyte subsets during low-grade inflammation through experimental endotoxemia in humans.Mitochondrial DNA and Toll-Like Receptor-9 Are Associated With Mortality in Critically Ill Patients.Hyperoxia Induces Inflammation and Cytotoxicity in Human Adult Cardiac Myocytes.Tissue factor is induced by interleukin-33 in human endothelial cells: a new link between coagulation and inflammation.Red cell distribution width and mortality in carotid atherosclerosis.Urokinase plasminogen activator protects cardiac myocytes from oxidative damage and apoptosis via hOGG1 induction.Components of the interleukin-33/ST2 system are differentially expressed and regulated in human cardiac cells and in cells of the cardiac vasculatureCan a flowchart improve the quality of bystander cardiopulmonary resuscitation?Cyclic and constant hyperoxia cause inflammation, apoptosis and cell death in human umbilical vein endothelial cells.Predictive value of low interleukin-33 in critically ill patients.Glycoprotein 130 polymorphism predicts soluble glycoprotein 130 levels.Pretreatment With Argon Protects Human Cardiac Myocyte-Like Progenitor Cells from Oxygen Glucose Deprivation-Induced Cell Death by Activation of AKT and Differential Regulation of Mapkinases.An increase of VEGF plasma levels is associated with restenosis of drug-eluting stents.Monocyte subset distribution is associated with mortality in critically ill patientsLevosimendan exerts anti-inflammatory effects on cardiac myocytes and endothelial cells in vitroHands-on training in acute cardiac careRhabdomyolysis during therapeutic hypothermia in a patient after successful cardio-pulmonary resuscitationEffects of AV-delay optimization on hemodynamic parameters in patients with VDD pacemakersInterleukin-33 induces urokinase in human endothelial cells--possible impact on angiogenesisN-terminal pro-brain natriuretic peptide and high-sensitivity troponin T exhibit additive prognostic value for the outcome of critically ill patientsIntestinal Fatty Acid Binding Protein is Associated With Mortality in Patients With Acute Heart Failure or Cardiogenic ShockPrevention is back in the spotlight - Highlights from American Heart Association Scientific Sessions 2018Release of mitochondrial DNA is associated with mortality in severe acute heart failureToll like receptor 2 and 9 expression on circulating neutrophils is associated with increased mortality in critically ill patientsNeutrophil extracellular traps and monocyte subsets at the culprit lesion site of myocardial infarction patientsCardioprotective cytokine interleukin-33 is up-regulated by statins in human cardiac tissueProtease-Activated Receptors 1 and 3 are Differentially Expressed on Human Monocyte Subsets and are Upregulated by Lipopolysaccharide Ex Vivo and In VivoThe prognostic value of serum amyloid A for long-term mortality among patients with subclinical carotid atherosclerosisGrowth differentiation factor-15 predicts poor survival after cardiac arrestAcute Cardiovascular Care 2019The ‘Young Acute Cardiovascular Care Association group’ of the Acute Cardiovascular Care Association
P50
Q28550861-5A2833D2-B800-48C0-B0EB-2A6819ED3E97Q34732457-D98D4EE5-3F92-4965-9101-FFCA38BDA801Q35153947-C1B3010D-F492-4C5C-97B7-A76AFE9DFF52Q35302588-3C018341-5B9F-4979-8066-E07A3D2EE551Q36258947-59820A36-5791-4B8A-9840-95195B26FFD6Q38138459-948C88CD-3ED4-4BEC-9FA3-1FFD9236982FQ38964211-0B2BC2F5-C50B-4E64-ACDE-6C7A1104FB06Q39573678-3DB1092F-FD26-4BC9-97B1-FFB784D54577Q40453006-946802D0-4137-41CB-83D8-9DDAA8FAC355Q40573717-AAA245A2-FCD0-439D-93F8-CEE5960911D8Q40942192-361525A1-F7CF-4FF8-ACDC-04D114A7F57EQ41017623-F5EB53DA-62C6-4569-AF88-CC5EF064CB69Q41028891-1E3B06A4-F312-4862-A981-CBE7A07D5B72Q42156210-D7EA3B5A-CE52-4BE9-833F-9CC07564C522Q44513589-F759E787-DA98-449F-BD00-FA901F03DFA3Q47636579-5C9036C6-319E-4886-803C-F26A1E2B8ABCQ49644455-B770EB12-5D22-451B-A164-7A67569BE63AQ50802337-058A5296-48A6-4617-A42D-1F61D8647FD4Q52586524-89D4E828-A1EB-41E9-81EE-1CCAF05BB1A4Q54374161-AAA992CC-3239-427E-806F-F74053ED585EQ58070723-41F303DF-20C8-468A-AA73-E970F12A8329Q58070876-7208ED5C-2132-4693-9B0E-0C97ED55A048Q61670782-1F286797-EF96-455E-9D19-2AA56BFB377DQ86308407-5EE78AF1-BEA2-424C-BB6C-A43CD89E4941Q87484692-D622BE71-3573-4D78-8ED2-87CF5725815DQ87614721-87B11616-1E2A-4C29-BB1C-0EA07BD82312Q88263355-1CB491CB-3002-47CA-A791-C81DB6BA4D10Q88919971-9E136D01-EA75-4C3A-9450-7194F3D52BE2Q90724415-E6913D47-A0F5-43AC-9A5A-B59A3DFD9D2EQ90995607-91B55DB1-274F-472F-ABDC-4E3BCC928F3FQ91120216-5998DAAB-9722-4DAE-8AEF-B2ADCC911F0DQ91198626-73064A82-8542-4875-B02D-F4A69875DD3CQ91450554-DC2FBC33-EF8A-48F7-B8D4-ADCF519A0375Q91771429-161E8627-B9D9-41BC-9716-5AFF5F525478Q91954657-8481AB64-22B6-4AA1-BBAE-3D196AD95FE0Q92499870-C1E12263-08B9-431B-86CB-4A1944B70BC7Q92937273-6EB66EA1-E2BA-48CB-AC18-DE21D374E46FQ95500341-A40B54BB-97A1-4336-8F4F-FB916901B970
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Konstantin A Krychtiuk
@ast
Konstantin A Krychtiuk
@en
Konstantin A Krychtiuk
@es
Konstantin A Krychtiuk
@nl
Konstantin A Krychtiuk
@sl
type
label
Konstantin A Krychtiuk
@ast
Konstantin A Krychtiuk
@en
Konstantin A Krychtiuk
@es
Konstantin A Krychtiuk
@nl
Konstantin A Krychtiuk
@sl
prefLabel
Konstantin A Krychtiuk
@ast
Konstantin A Krychtiuk
@en
Konstantin A Krychtiuk
@es
Konstantin A Krychtiuk
@nl
Konstantin A Krychtiuk
@sl
P106
P21
P31
P496
0000-0001-7792-2837